The World health Organization is recommending the use of the HIV drug dolutegravir (DTG) as the preferred drug for HIV treatment globally. The decision of the global health body is based on  new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line […]